iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Glenmark Pharmaceuticals on Monday announced that it has received final approval by the United States Food & Drug Administration (USFDA) for its lacosamide tablets.

image

Hindalco Industries Ltd has added 12.39% over last one month compared to 9.56% gain in S&P BSE Metal index and 0.04% drop in the SENSEX

image

Atul rose 2.27% to Rs 9933.60 after the company said its board will consider a share buyback on 25 March 2022.

image

The interim dividend declared will be paid on or after April 05, 2022.

image

The companys board on Friday (18 March) declared an interim dividend of Rs 3.75 per share.

image

RRVL acquires 89% equity stake in Purple Panda Fashions, which owns and operates the Clovia business Founding team to continue to drive the business in the next phase of growth.

image

Zydus Lifesciences (formerly known as Cadila Healthcare) received Prior Approval Supplement (PAS) approval from the USFDA to market Mycophenolate Mofetil for Injection USP, 500 mg/vial (US RLD: CellCept injection).

image

Wockhardt announced a collaboration with Serum Life Sciences UK Ltd, a subsidiary of the Serum Institute of India, to deliver a global vaccine programme.

image

The domestic equity barometers traded with modest losses in early trade. The Nifty as trading below the 17,300 mark. Metals, IT and healthcare stocks advanced while FMCG, banks and financials shares declined. At 09:21 IST, the barometer index, the S&P BSE Sensex, was down 72.01 points or 0.12% to 57,791.92. The Nifty 50 index lost 14.25 points or 0.08% to 17,272.80. Hindalco (up 3.69%), Maruti […]

image

Business Wire IndiaSouth Asia’s largest & Asia’s leading higher EdTech major – upGrad, today reported turning a profit spurred by a 150% growth Y-o-Y in revenues and a stable 70% gross margin, across all its income streams.    upGrad is now well-positioned as the most integrated Higher Edtech company in the world – spanning all aspects of LifeLongLearning from undergrad courses, test prep, on-campus learning, […]

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.